Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 2
1954 1
1955 1
1956 2
1957 3
1958 1
1959 1
1961 2
1962 5
1963 5
1964 5
1965 4
1966 4
1967 7
1968 13
1969 23
1970 26
1971 12
1972 8
1973 9
1974 19
1975 11
1976 8
1977 8
1978 10
1979 7
1980 11
1981 9
1982 4
1983 8
1984 11
1985 19
1986 11
1987 17
1988 18
1989 16
1990 18
1991 17
1992 18
1993 17
1994 14
1995 15
1996 20
1997 20
1998 18
1999 33
2000 28
2001 28
2002 38
2003 34
2004 29
2005 26
2006 58
2007 44
2008 50
2009 69
2010 77
2011 82
2012 94
2013 83
2014 84
2015 112
2016 118
2017 126
2018 116
2019 90
2020 77
Text availability
Article attribute
Article type
Publication date

Search Results

1,782 results
Results by year
Filters applied: . Clear all
Page 1
Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.
Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, Kunugi H. Hidese S, et al. Among authors: ota m. Nutrients. 2019 Oct 3;11(10):2362. doi: 10.3390/nu11102362. Nutrients. 2019. PMID: 31623400 Free PMC article. Clinical Trial.
Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study.
Hidese S, Ota M, Wakabayashi C, Noda T, Ozawa H, Okubo T, Kunugi H. Hidese S, et al. Among authors: ota m. Acta Neuropsychiatr. 2017 Apr;29(2):72-79. doi: 10.1017/neu.2016.33. Epub 2016 Jul 11. Acta Neuropsychiatr. 2017. PMID: 27396868 Clinical Trial.
Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.
Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H. Ota M, et al. Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24. Neurosci Lett. 2019. PMID: 30367958 Free article. Clinical Trial.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. Zak DE, et al. Among authors: ota m. Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24. Lancet. 2016. PMID: 27017310 Free PMC article.
Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Fujita S, et al. Among authors: ota m. Ann Surg. 2017 Aug;266(2):201-207. doi: 10.1097/SLA.0000000000002212. Ann Surg. 2017. PMID: 28288057 Clinical Trial.
Pseudo-onychomycosis.
Ota M. Ota M. Lancet Infect Dis. 2017 Feb;17(2):235. doi: 10.1016/S1473-3099(16)30136-0. Lancet Infect Dis. 2017. PMID: 28134122 No abstract available.
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.
Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. Ito A, et al. Among authors: ota m. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01454-17. doi: 10.1128/AAC.01454-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29061741 Free PMC article.
Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.
Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K, Kunugi H. Aizawa E, et al. Among authors: ota m. J Affect Disord. 2016 Sep 15;202:254-7. doi: 10.1016/j.jad.2016.05.038. Epub 2016 May 24. J Affect Disord. 2016. PMID: 27288567
Will we see protection or reinfection in COVID-19?
Ota M. Ota M. Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0316-3. Nat Rev Immunol. 2020. PMID: 32303697 Free PMC article. No abstract available.
Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth.
Sato D, Takahata M, Ota M, Fukuda C, Tsuda E, Shimizu T, Okada A, Hiruma Y, Hamano H, Hiratsuka S, Fujita R, Amizuka N, Hasegawa T, Iwasaki N. Sato D, et al. Among authors: ota m. Bone. 2018 Nov;116:172-180. doi: 10.1016/j.bone.2018.07.026. Epub 2018 Aug 2. Bone. 2018. PMID: 30076992
1,782 results
Jump to page
Feedback